News | 05 December 2012
Building on our recent investment in a Lilly-branded generics platform in China earlier this year, this agreement will help Lilly expand its portfolio and deliver high-quality cancer medicines to patients across emerging markets.? Arun Kumar, Founder ...
Click on the link to read the full article at Hindu Business Line
(This link will open in a new window)